Vidal-Real C, Prez-Sayns M, Surez-Pearanda JM, Gndara-Rey JM, Garca-Garca A. Osteonecrosis of the jaws in 194 patients who have
undergone intravenous bisphosphonate therapy in Spain. Med Oral Patol Oral Cir Bucal. 2015 May 1;20
(3):e267-72.
doi:10.4317/medoral.20092
http://dx.doi.org/doi:10.4317/medoral.20092
|
1.
American Dental Association Council onScientificAffairs. Dental management
of patientsreceiving oral bisphosphonatetherapy:
expert panel recommendations.
J Am DentAssoc. 2006;137:1144-50. |
|
|
|
|
|
2.
Marx RE. Pamidronate (Aredia)
and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing
epidemic. J Oral Maxillofac
Surg. 2003;61:1115-7. |
|
|
|
|
|
3.
Allen MR, Burr DB. Thepathogenesis
of bisphosphonate-relatedosteonecrosis of thejaw: so manyhypotheses, so few data. J Oral MaxillofacSurg.
2009;67:61-70. |
|
|
|
|
|
4.
Yin G, Bai Y, Luo E. Angiogenicsuppression of osteoclastsmayplay
a role in developingbisphosphonate-relatedosteonecrosisof
thejaw. MedHypotheses.
2011;76:347-9. |
|
|
|
|
|
5.
Otto S, Schreyer C, Hafner
S, Mast G, Ehrenfeld M, Sturzenbaum S, et al. Bisphosphonate-relatedosteonecrosis
of thejaws - characteristics,
riskfactors, clinicalfeatures,
localization and impactononcologicaltreatment.
J CraniomaxillofacSurg. 2012;40:303-9. |
|
|
|
|
|
6. Hoff AO, Toth B, Hu M, Hortobagyi GN, Gagel RF. Epidemiology and riskfactorsforosteonecrosis of thejaw
in cancerpatients. Ann N Y AcadSci.
2011;1218:47-54. |
|
|
|
|
|
7. Dimopoulos MA, Kastritis E, Bamia C, Melakopoulos I, Gika D, Roussou M, et al. Reduction of osteonecrosis of thejaw (ONJ) afterimplementation
of preventivemeasures in patientswithmultiplemyelomatreatedwithzoledronicacid.
Ann Oncol. 2009;20:117-20. |
|
|
|
|
|
8. Yamazaki T, Yamori M, Ishizaki T, Asai K, Goto K, Takahashi K, et al. Increasedincidence of osteonecrosis
of thejawaftertoothextraction in patientstreatedwithbisphosphonates: a cohortstudy.
Int J Oral MaxillofacSurg.
2012;41:1397-403. |
|
|
|
|
|
9. Bagan JV, Jimenez Y, Diaz JM, Murillo J, Sanchis JM,
Poveda R, et al. Osteonecrosis of thejaws in intravenousbisphosphonate
use: Proposalfor a modification
of theclinicalclassification. Oral Oncol. 2009;45:645-6. |
|
|
|
|
|
10. Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D, et
al. Bisphosphonate-associatedosteonecrosis of thejaw: report of a taskforce of the American SocietyforBone and Mineral Research.
J BoneMiner Res. 2007;22:1479-91. |
|
|
|
|
|
11.
King AE, Umland EM. Osteonecrosis
of thejaw in patientsreceivingintravenousor
oral bisphosphonates. Pharmacotherapy.
2008;28:667-77. |
|
|
|
|
|
12. McLeod NM, Brennan PA, Ruggiero SL. Bisphosphonateosteonecrosis
of thejaw: a historical
and contemporaryreview. Surgeon.
2012;10:36-42. |
|
|
|
|
|
13. Bagan J, Scully C, Sabater V, Jimenez Y. Osteonecrosis of thejaws in patientstreatedwithintravenousbisphosphonates
(BRONJ): A conciseupdate. Oral Oncol.
2009;45:551-4. |
|
|
|
|
|
14. Vandone AM, Donadio M, Mozzati M, Ardine M, Polimeni MA, Beatrice S, et al. Impact
of dental care in theprevention
of bisphosphonate-associatedosteonecrosis of thejaw: a single-center clinicalexperience.
Ann Oncol. 2012;23:193-200. |
|
|
|
|
|
15. Vahtsevanos K, Kyrgidis A, Verrou E, Katodritou E, Triaridis S, Andreadis CG, et
al. Longitudinal cohortstudy of riskfactors
in cancerpatients of bisphosphonate-relatedosteonecrosis
of thejaw. J ClinOncol.
2009;27:5356-62. |
|
|
|
|
|
16.
Bocanegra-Perez MS, Vicente-Barrero M, Sosa-Henriquez M, Rodriguez-Bocanegra
E, Liminana-Canal JM, Lopez-Marquez
A, et al. Bonemetabolism and clinicalstudy
of 44 patientswithbisphosphonate-relatedosteonecrosis
of thejaws. Med Oral
Patol Oral Cir Bucal. 2012;17:e948-55. |
|
|
|
|
|
17. Mozzati M, Martinasso G, Maggiora M, Scoletta M, Zambelli M, Carossa S, et al.
Oral mucosa produces cytokines and factorsinfluencingosteoclastactivity and endothelialcellproliferation, in patientswithosteonecrosis
of jawaftertreatmentwithzoledronicacid. Clin Oral Investig.
2013;17:1259-66. |
|
|
|
|
|
18. Bonacina R, Mariani U, Villa F, Villa A. Preventivestrategies and clinicalimplicationsforbisphosphonate-relatedosteonecrosis
of thejaw: a review of
282 patients. J Can DentAssoc.
2011;77:147. |
|
|
|
|
|
19. Jimenez-Soriano Y, Bagan JV. Bisphosphonates, as a new cause of drug-inducedjawosteonecrosis:
anupdate. Med Oral Patol
Oral Cir Bucal. 2005;10 Suppl
2:E88-91. |
|
|
|
|
|
20. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63
cases. J Oral Maxillofac Surg.
2004;62:527-34. |
|
|
|
|
|
21. Rugani P, Acham S, Truschnegg A, Obermayer-Pietsch
B, Jakse N. Bisphosphonate-associatedosteonecrosis
of thejaws: surgicaltreatmentwithErCrYSGG-laser.
Case report. Oral Surg
Oral Med Oral Pathol Oral
RadiolEndod. 2010;110:e1-e6. |
|
|
|
|
|
22. Vescovi P, Manfredi M, Merigo E, Meleti M, Fornaini C, Rocca J, et al. Surgicalapproachwith Er: YAG laser onosteonecrosis
of thejaws (ONJ) in patientsunderbisphosphonatetherapy
(BPT). Lasers Med Sci. 2010;25:101-13. |
|
|
|
|
|
23. Fournier P, Boissier S, Filleur S, Guglielmi J, Cabon F, Colombel M, et al. Bisphosphonatesinhibitangiogenesis in vitro and testosterone-stimulated vascular regrowth
in the ventral prostate
in castratedrats. Cancer
Res. 2002;62:6538-44. |
|
|
|
|
|
24. Perez SB, Barrero MV, Hernandez
MS, Knezevic M, Navarro JM, Millares JR. Bisphosphonate-associatedosteonecrosis of thejaw.A proposalforconservativetreatment.
Med Oral Patol Oral Cir
Bucal. 2008;13:E770-3. |
|
|
|
|
|
25. Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx
RE, Mehrotra B. American Association
of Oral and MaxillofacialSurgeons position paperonbisphosphonate-relatedosteonecrosis of thejaw - 2009 update. AustEndod J. 2009;35:119-30. |
|
|
|
|
|
26. Bagan J, Blade J, Cozar JM, Constela M, Garcia
Sanz R, GomezVeiga F, et al. Recommendationsfortheprevention,
diagnosis, and treatment of osteonecrosis
of thejaw (ONJ) in cancerpatientstreatedwithbisphosphonates.
Med Oral Patol Oral Cir
Bucal. 2007;12:E336-40. |
|
|
|
|
|
27. Ripamonti CI, Maniezzo M, Campa
T, Fagnoni E, Brunelli C,
Saibene G, et al. Decreasedoccurrence
of osteonecrosis of thejaw
after implementation of
dental preventive measures
in solidtumourpatientswithbonemetastasestreatedwithbisphosphonates. Theexperience of the National CancerInstitute of Milan. Ann Oncol.
2009;20:137-45. |
|
|
|
|